about
Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activityCancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyInteraction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alphaA new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathwayHypoxia-induced modulation of apoptosis and BCL-2 family proteins in different cancer cell typesEnhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiencyPhosphorescence monitoring of hypoxic microenvironment in solid-tumors to evaluate chemotherapeutic effects using the hypoxia-sensitive iridium (III) coordination compounduPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.Redox- and hypoxia-responsive MRI contrast agents.Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic processHypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progressionRegulation of G(1) arrest and apoptosis in hypoxia by PERK and GCN2-mediated eIF2alpha phosphorylation.Galectins and gliomas.HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.Autophagy inhibits chemotherapy-induced apoptosis through downregulating Bad and Bim in hepatocellular carcinoma cells.Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alphaAcid activation of Trpv1 leads to an up-regulation of calcitonin gene-related peptide expression in dorsal root ganglion neurons via the CaMK-CREB cascade: a potential mechanism of inflammatory pain.Genetic screening of new genes responsible for cellular adaptation to hypoxia using a genome-wide shRNA library.Protein N-terminal acetyltransferases in cancer.The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT).Impact of preoperative anemia on relapse and survival in breast cancer patients.The archipelago ubiquitin ligase subunit acts in target tissue to restrict tracheal terminal cell branching and hypoxic-induced gene expression.Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylasesEffects of hypoxia on human cancer cell line chemosensitivity.In vivo nonlinear spectral imaging as a tool to monitor early spectroscopic and metabolic changes in a murine cutaneous squamous cell carcinoma model.Transcriptional regionalization of the fruit fly's airway epithelium.Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistanceThe biology of cancer stem cells and its clinical implication in hepatocellular carcinoma.Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain.Clostridial spores for cancer therapy: targeting solid tumour microenvironmentHIF-1 at the crossroads of hypoxia, inflammation, and cancer.Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell linesTissue dynamics spectroscopy for phenotypic profiling of drug effects in three-dimensional culture.Role of heparan sulfatases in ovarian and breast cancer.Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes.Preoperative anemia, blood transfusion, and neutrophil-to-lymphocyte ratio in patients with stage i non-small cell lung cancer.
P2860
Q21245725-51193D03-1C7F-4470-9377-65C64D109F28Q24652502-FA2F50ED-23A8-49A4-80E9-EDA036D4B2B8Q28281963-E521A0D8-59DD-49E0-A3F0-F5435E59AF86Q28307285-D1612DD2-A9E7-4787-8A0F-654AC6D760B8Q28484877-DEE820DB-5A92-4203-A62A-70AE73586557Q28509277-E1285369-2B88-4A01-BEFF-3277E97BBD65Q28544651-B4463AAD-87D2-4381-9C65-5903542527AAQ30443804-51BC74E6-4909-4737-A6C5-2757CB87FF5CQ30820031-A074165B-0872-434E-9CF7-75088822EAE5Q30826843-AD7D5192-0856-47F1-9147-A7D3C892B168Q33271702-D2F62C0C-F2E6-4932-B879-5ED87F7E578FQ33382510-81A4DAFD-9BA1-46BE-B15F-0202D23032FDQ33588288-BCF327B4-6A55-42B0-B205-710DB14EA58AQ33588438-C34218B1-D4AA-4B32-8838-32D23EF6FF6AQ33642200-CBFCD365-E1C3-44E0-AF8C-38D97B844A92Q33781222-5E929A25-0C70-4819-A933-100264B5D919Q33852396-8D9E0777-74F3-4CE7-8257-E0FDBDAD320FQ34009839-4C29E217-D5F3-4366-94C5-78277B31EA63Q34029307-708BAAE1-B7B1-4965-836D-2855F785A14EQ34241899-ED6D4D46-E781-4571-890A-C14049B4DBE3Q34258775-08A32581-16F9-4012-A1DB-D9CE32A78753Q34479984-1518DBB3-DE2D-4974-890E-707A571A150DQ34490499-EFD6199F-F3FA-4745-8DB3-CEC366646D98Q34565736-86534DF9-9F5B-4653-B16F-2D03E92F53C7Q34607947-EDE3A2EC-1B60-4569-BAA0-F59523D91C43Q34799489-3E66ADE3-2160-46AB-8835-C9D2CCC6EBA6Q34799788-211768D2-CCA6-41FF-B132-11FC0AAD301EQ34848837-33B39172-DBCB-4227-B446-16AE8B1DF716Q35206468-F2A85571-A1A0-4BAD-95D3-5E705BE441D0Q35219886-2DD88C3B-8936-41D8-AF09-C6DA01A157C4Q35778321-2D7224D9-EA33-42E6-9143-7CC2689A4CE7Q35880778-33C6408B-3855-470D-9CAB-9BBA60E17292Q36001671-AE16ED05-3BF1-42A3-95C7-5E180F227811Q36037633-78FB8B0A-51C9-493A-96ED-504A7424FB4AQ36070195-EC95A0AC-306B-465C-89E7-2878EAA3D3ABQ36177149-225BE248-3348-43E5-8D99-5E82C400FAD2Q36383804-D53C48CB-36D0-4306-884E-3129C364BD40Q36562888-20F2283D-1A57-4D1C-9325-905C476B0E02Q36610161-CC162DF3-BE2B-421E-9C0C-456918381A88Q36640650-C8301BC5-FD7F-4D57-9AAF-03DA46C4CD64
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Tumor hypoxia and cancer progression.
@ast
Tumor hypoxia and cancer progression.
@en
type
label
Tumor hypoxia and cancer progression.
@ast
Tumor hypoxia and cancer progression.
@en
prefLabel
Tumor hypoxia and cancer progression.
@ast
Tumor hypoxia and cancer progression.
@en
P1433
P1476
Tumor hypoxia and cancer progression
@en
P2093
Steffen Schnitzer
P356
10.1016/J.CANLET.2005.05.028
P407
P577
2005-07-05T00:00:00Z